Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:sedative
gptkb:benzodiazepine |
| gptkbp:administered_via |
oral
|
| gptkbp:ATCCode |
N05CA06
|
| gptkbp:CASNumber |
76-27-5
|
| gptkbp:chemical_compound |
C10H12N2O3
|
| gptkbp:discoveredBy |
1930s
|
| gptkbp:excretion |
gptkb:kidney
|
| gptkbp:hasInChIKey |
QJQYQZPXZQYEME-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
O=C1NC(=O)NC(=O)C1(CC2=CCCCC2)CC
|
| gptkbp:hasUNII |
6K3WJA5Z1T
|
| gptkbp:IUPACName |
5-cyclohex-2-en-1-yl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
|
| gptkbp:legalStatus |
prescription only (varies by country)
|
| gptkbp:marketedAs |
Dormisan
Phanodorm |
| gptkbp:meltingPoint |
110°C
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
208.22 g/mol
|
| gptkbp:PubChem_CID |
6137
5910 |
| gptkbp:relatedTo |
phenobarbital
barbital |
| gptkbp:sideEffect |
drowsiness
respiratory depression dependence |
| gptkbp:synonym |
cyclobarbitol
cyclobarbitone |
| gptkbp:usedFor |
gptkb:sedative
gptkb:hypnotic |
| gptkbp:bfsParent |
gptkb:Bamital
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
cyclobarbital
|